← all drugs
Remifentanil Hydrochloride Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-08-25
Day 1,519
of this shortage, counting from the FDA's first posting on 06/28/2022
- Manufacturers listed
- Mylan Institutional, a Viatris Company, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.
- Reported reason(s)
- Delay in shipping of the drug; Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (9)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Ultiva, Injection, 2 mg (NDC 72078-035-02) | Mylan Institutional, a Viatris Company | Available | 08/20/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Hikma Pharmaceuticals USA, Inc. | Available | 08/13/2026 |
| Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Mylan Institutional, a Viatris Company | Available | 08/20/2026 |
| Ultiva, Injection, 5 mg (NDC 72078-036-05) | Mylan Institutional, a Viatris Company | Available | 08/20/2026 |
| Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Fresenius Kabi USA, LLC | Available | 08/04/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Fresenius Kabi USA, LLC | Available | 08/04/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.